AAAAAA

   
Results: 1-18 |
Results: 18

Authors: WIERNIK PH MOORE DF BENNETT JM VOGL SE HARRIS JE LUGER S OKEN MM GLICK JH
Citation: Ph. Wiernik et al., PHASE-II STUDY OF MITOGUAZONE, CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE AND PREDNISONE FOR PATIENTS WITH DIFFUSE HISTOLOGIC SUBTYPES OF NON-HODGKINS-LYMPHOMA - AN EASTERN-COOPERATIVE-ONCOLOGY-GROUP STUDY (PE481), Leukemia & lymphoma, 30(5-6), 1998, pp. 601-607

Authors: JUWEID M BHATNAGAR A SHARKEY RM STADMAUER E LUGER S BURTON J STEIN R ALAVI A GOLDENBERG DM
Citation: M. Juweid et al., INITIAL CLINICAL-EXPERIENCE WITH I-131 HUMANIZED LL2 (I-131-HLL2) ANTI-CD22 MAB AGAINST B-CELL MALIGNANCIES, The Journal of nuclear medicine, 39(5), 1998, pp. 273-273

Authors: LUGER S
Citation: S. Luger, IMMUNIZATION AGAINST LYME-DISEASE, The New England journal of medicine, 339(22), 1998, pp. 1637-1638

Authors: PERL E SHUFMAN E VAS A LUGER S STEINER JE
Citation: E. Perl et al., TASTE-REACTIVITY AND ODOR-REACTIVITY IN HEROIN-ADDICTS, Israel journal of psychiatry and related sciences, 34(4), 1997, pp. 290-299

Authors: STIFF P EMMANOUILIDES C LUGER S HARMAN G LEMAISTRE CF BROWN R PERRY J MASON JR LIST A BENSINGER W FRETER D SCHENKEIN D BRANNAN C OLSON E WYRES M WHEELER C
Citation: P. Stiff et al., USE OF STEM-CELL FACTOR PLUS FILGRASTIM IMPROVES PBPC COLLECTION IN HEAVILY PRETREATED PATIENTS WITH LYMPHOMA OR HODGKINS-DISEASE, Experimental hematology, 25(8), 1997, pp. 359-359

Authors: STIFF P GINGRICH R LUGER S BROWN RA LEMAISTRE CF PERRY J SCHENKEIN D LIST A MASON JR BENSINGER W WHEELER CA FRETER C MURPHYFILKINS R WYRES M PARKER W EMMANOUILIDES C
Citation: P. Stiff et al., IMPROVED PBPC COLLECTION USING STEMGEN(R) (STEM-CELL FACTOR, SCF) ANDFILGRASTIM (G-CSF) COMPARED TO G-CSF ALONE IN HEAVILY PRETREATED LYMPHOMA (NNL) AND HODGKINS-DISEASE (HD) PATIENTS (PTS), Blood, 90(10), 1997, pp. 2628-2628

Authors: GEWIRTZ AM LUGER S SOKOL D GOWDIN B STADTMAUER E RECCIO A RATAJCZAK MZ
Citation: Am. Gewirtz et al., TREATING HUMAN MYELOGENOUS LEUKEMIA WITH C-MYB ANTISENSE OLIGODEOXYNUCLEOTIDES - 2 YEARS CLINICAL-EXPERIENCE, Journal of investigative medicine, 44(3), 1996, pp. 279-279

Authors: BIRD JM LUGER S MANGAN P EDELSTEIN M SILBERSTEIN L POWLIS W BALL J SCHULTZ DJ STADTMAUER EA
Citation: Jm. Bird et al., 4-HYDROPEROXYCYCLOPHOSPHAMIDE PURGED AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN NON-HODGKINS-LYMPHOMA PATIENTS AT HIGH-RISK OF BONE-MARROW INVOLVEMENT, Bone marrow transplantation, 18(2), 1996, pp. 309-313

Authors: GEWIRTZ AM LUGER S SOKOL D GOWDIN B STADTMAUER E RECCIO A RATAJCZAK MZ
Citation: Am. Gewirtz et al., OLIGODEOXYNUCLEOTIDE THERAPEUTICS FOR HUMAN MYELOGENOUS LEUKEMIA - INTERIM RESULTS, Blood, 88(10), 1996, pp. 1069-1069

Authors: LEE B ZHANG Q WEYLAND C ECK S LUGER S KAMOUN M WASIK M
Citation: B. Lee et al., CONSTITUTIVE ACTIVATION OF THE IL-2R COMMON GAMMA-CHAIN (IL-2R-GAMMA ASSOCIATED JAK STAT PATHWAY IN IL-2 INDEPENDENT, BUT NOT IN IL-2 DEPENDENT CELL-LINES AND FRESHLY ISOLATED TUMOR-CELLS DERIVED FROM PATIENTSWITH ADULT T-CELL LYMPHOMA/LEUKEMIA (ATLL)/, Blood, 88(10), 1996, pp. 1517-1517

Authors: GOODMAN JC BRADLEY JF ROSS AE GOELLNER P LAGUS A VITALE B BERGER BW LUGER S JOHNSON RC
Citation: Jc. Goodman et al., BLOOD-STREAM INVASION IN EARLY LYME-DISEASE - RESULTS FROM A PROSPECTIVE, CONTROLLED, BLINDED STUDY USING THE POLYMERASE CHAIN-REACTION (VOL 99, PG 6, 1995), The American journal of medicine, 101(2), 1996, pp. 239-239

Authors: CLEVENGER CV NGO W SOKOL DL LUGER S GEWIRTZ AM
Citation: Cv. Clevenger et al., VAV IS NECESSARY FOR PROLACTIN-STIMULATED PROLIFERATION AND IS TRANSLOCATED INTO THE NUCLEUS OF A T-CELL LINE, The Journal of biological chemistry, 270(22), 1995, pp. 13246-13253

Authors: LUGER S
Citation: S. Luger, BATTLING WALL-STREET - THE KENNEDY PRESIDENCY - GIBSON,D, The Journal of American history, 82(2), 1995, pp. 842-843

Authors: STADTMAUER E LUGER S BIRD J MANGAN P SICKLES C GAULT E MAGEE D SILBERSTEIN L
Citation: E. Stadtmauer et al., CYCLOPHOSPHAMIDE (CYT) ENHANCES G-CSF MOBILIZED CD34-BLOOD PROGENITOR-CELL (PSC) COLLECTION IN PATIENTS WITH RESPONDING METASTATIC BREAST-CANCER (MBC) AT THE EXPENSE OF INCREASED TOXICITY AND COST( PERIPHERAL), Blood, 86(10), 1995, pp. 3953-3953

Authors: GOODMAN JL BRADLEY JF ROSS AE GOELLNER P LAGUS A VITALE B BERGER BW LUGER S JOHNSON RC
Citation: Jl. Goodman et al., BLOOD-STREAM INVASION IN EARLY LYME-DISEASE - RESULTS FROM A PROSPECTIVE, CONTROLLED, BLINDED STUDY USING THE POLYMERASE CHAIN-REACTION, The American journal of medicine, 99(1), 1995, pp. 6-12

Authors: PODREKA I BAUMGARTNER C AULL S KOCH G PIETRCZYK U LINDINGER G OLBRICH A HITTMAIER K LUGER S BRUCKE T WIMBERGER D
Citation: I. Podreka et al., PREOPERATIVE SEIZURE MONITORING WITH HMPAO - SPECT PROLONGED EEG AND MRI, The Journal of nuclear medicine, 35(5), 1994, pp. 160000207-160000208

Authors: KAHN MJ STADTMAUER EA EDELSTEIN M SALHANEY K LUGER S SKALLA K NOWELL P BERGER M
Citation: Mj. Kahn et al., INTERMITTENT ALL-TRANS-RETINOIC ACID (ATRA) FOR THE TREATMENT OF MYELODYSPLASIA (MDS), Blood, 84(10), 1994, pp. 10000632-10000632

Authors: LUGER S SCHEUERMAN W
Citation: S. Luger et W. Scheuerman, TEACHING AMERICAN GOVERNMENT, PS, political science & politics, 26(4), 1993, pp. 749-753
Risultati: 1-18 |